z-logo
Premium
Paediatric arterial ischaemic stroke and cerebral sinovenous thrombosis in Denmark 1994–2006: A nationwide population‐based study
Author(s) -
Tuckuviene R,
Christensen AL,
Helgestad J,
Johnsen SP,
Kristensen SR
Publication year - 2011
Publication title -
acta paediatrica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.772
H-Index - 115
eISSN - 1651-2227
pISSN - 0803-5253
DOI - 10.1111/j.1651-2227.2010.02100.x
Subject(s) - medicine , incidence (geometry) , pediatrics , population , case fatality rate , stroke (engine) , thrombosis , surgery , mechanical engineering , physics , environmental health , optics , engineering
Aim:  To assess the incidence rates (IR), clinical characteristics, risk factors, treatment and outcomes of paediatric arterial ischaemic stroke (AIS) and cerebral sinovenous thrombosis (CSVT). Methods:  Using population‐based, nationwide medical registries, we identified all patients aged 0–18 years at the time of hospitalization with first‐ever AIS and/or CSVT in Denmark between 1994 and 2006. Medical records were retrieved and reviewed. Results:  We identified 211 patients with AIS and 40 patients with CSVT corresponding to IRs of 1.33 (95% CI 1.16–1.52) and 0.25 (95% CI 0.19–0.34) per 100 000 person‐years, respectively. The IRs peaked in infancy (<1 year) for both AIS and CSVT with an additional peak among adolescents (15–18 years) for CSVT. The IR of AIS increased 3.9% per year (p = 0.036), whereas no changes were found for CSVT. In total, 48.2% of the patients received antithrombotic treatment; no major complications were observed. All‐cause and thrombosis‐related 30‐day case fatality ratios were 3.6% and 2.4%, respectively; neurological sequelae were found in 56.2% of patients. Conclusion:  The IR of AIS was highest in infants and had increased with 3.9% annually during the observation period. The IR of CSVT had an additional peak in adolescence and remained unchanged over time.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here